Cat#: | RP-3103H |
Product Name: | Recombinant Human EPO a Protein, HEK |
Synonym: | Erythropoietin-Alpha, EPO-a, EPO-alpha, Epoetin, EP, MGC138142. |
Description: | EPO-a Protein produced in HEK cells is a glycosylated monomer, having a total molecular weight of 36kDa. The EPO-alpha is purified by proprietary chromatographic techniques. |
Source: | HEK. |
Purity: | Greater than 95% as obsereved by SDS-PAGE. |
Bioactivity: | The specific activity was determined by the dose-dependent stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) and is typically 0.5-2.5ng/ml, corresponding to a specific activity of 400,000-2,000,000 units/mg. |
Formulation: | The EPO-alpha was lyophilized from 1mg/ml in 1xPBS. |
Stability: | Recombinant Proteins are stable for up to 1 year from date of receipt at -70℃ |
Reconstitution: | It is recommended to reconstitute the lyophilized EPO-alpha in sterile water not less than 100µg/ml, which can then be further diluted to other aqueous solutions. |
Storage: | Lyophilized EPO-alpha although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution EPO-alpha should be stored at 4°C between 2-7 days and for future use below -18°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles. |